Literature DB >> 21429631

Design and synthesis of protein-protein interaction mimics as Plasmodium falciparum cysteine protease, falcipain-2 inhibitors.

Luca Rizzi1, Srividhya Sundararaman, Katarina Cendic, Nadia Vaiana, Reshma Korde, Dipto Sinha, Asif Mohmmed, Pawan Malhotra, Sergio Romeo.   

Abstract

Small peptides that mimic the protein-protein interactions between falcipain-2 and egg white cystatin, an endogenous inhibitor of cysteine proteases, were designed and synthesized and their effects on falcipain-2 activity were analyzed. The mimics are characterized by the presence of different linkers: γ-aminobutyric acid, cis-4-aminocyclohexane carboxylic acid and a macrocycle formed by GABA and two cysteines joined by a disulfide linkage. Some of these compounds showed falcipain-2 inhibition in the micromolar range and produced morphological abnormalities in the Plasmodium food vacuole. Although these peptides are less potent than cystatin, considering the reduction of amino acid residues and the capacity to cross membranes, this approach could be an interesting starting point for the development of a new class of anti-malarial drugs.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21429631     DOI: 10.1016/j.ejmech.2011.02.061

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Centenary celebrations article: Cysteine proteases of human malaria parasites.

Authors:  Kailash C Pandey
Journal:  J Parasit Dis       Date:  2011-12-03

Review 2.  New insight-guided approaches to detect, cure, prevent and eliminate malaria.

Authors:  Sushil Kumar; Renu Kumari; Richa Pandey
Journal:  Protoplasma       Date:  2014-10-17       Impact factor: 3.356

3.  Structure-function of falcipains: malarial cysteine proteases.

Authors:  Kailash C Pandey; Rajnikant Dixit
Journal:  J Trop Med       Date:  2012-02-19

4.  Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design.

Authors:  Thommas Mutemi Musyoka; Joyce Njoki Njuguna; Özlem Tastan Bishop
Journal:  Malar J       Date:  2019-05-03       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.